CLIENTS
Projects that AfRx Consulting has supported include
-
Future of Global Health Procurement for the Center for Global Development: Leading a team of consultants to investigate, compile and analyse sources of health commodity data for LICs and LMICs worldwide to comment on the past, present and future health commodity and procurement needs of developing nations.
​
-
Capability and Market Assessment of Health Product Wholesalers and Distributors in Kenya, Nigeria, Senegal, Uganda and Tanzania: Providing data procurement and analytical support, in-country interviews, background, landscaping and report writing. Project is currently ongoing until Q3 2019.
​
-
Pharmaceutical affordability studies using the Economist Intelligence Unit’s Canback database: Supporting EIU engagements with top 20 global pharmaceutical manufacturers to examine sub-national income and wealth in developing markets to better understand ability and willingness to pay for treatments in developing markets.
​
-
Health commodity procurement evaluation for the Ukrainian Government: Performance analysis against international reference prices, calculate input cost change and evaluation against previous procurement performance;
​
-
Consultations and diagnostic assessment of the private pharmaceutical sector in Kenya: Tasked with conducting primary and secondary research for impact investor looking at potential skills development and supply chain interventions.
​
-
SG Report on Resource Flows for Further Implementation of ICPD PoA: Supporting UNFPA in a consulting capacity to create a set of recommendations around global data availability to improve transparency on financial flows for reproductive health.
​
-
USAID Regional Action on Data (US$22m project): Project support as African health data specialist and to supplement the project during design phase; Landscaping data availability, gap analysis, investment options and strategic recommendations.
​
-
Market access strategy for low-middle income countries for a top 20 global pharmaceutical company: Competitor analysis, market access strategy, sales model building and evaluation of potential initiatives to provide affordable access to two blockbuster drugs (NOAC, Oncology) across Africa, Asia and LatAm.